The role of growth hormone and insulin-like growth factors in the immune system

Cellular and Molecular Life Sciences

Volumn 54, Issue 10, 1998, Pages 1083-1094

  Van Buul Offers, S C ^a   Kooijman, R ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Growth hormone; Immune system; Insulin like growth factor binding proteins; Insulin like growth factor I and II; Transgenic mice

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; GROWTH HORMONE RECEPTOR; INTERLEUKIN 1; SOMATOMEDIN; SOMATOMEDIN RECEPTOR;

ARTICLE; DIFFERENTIATION; ENDOCRINE FUNCTION; HUMAN; IMMUNE SYSTEM; NONHUMAN;

ANIMALS; GROWTH HORMONE; HUMANS; IMMUNE SYSTEM; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; RECEPTOR, IGF TYPE 1; RECEPTORS, SOMATOTROPIN;

EID: 0031751086     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050237     Document Type: Article

References (160)

1. Clark R. (1997) The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr. Rev. 18: 157-179
2. Kooijman R., Hooghe-Peters E. L. and Hooghe R. (1996) Prolactin, growth hormone and insulin-like growth factor-1 in the immune system. Adv. Immunol. 63: 377-454
3. Mandrup-Poulsen T., Nerup J., Reimers J. I., Pociot F., Andersen H. U., Karlsen A., Bjerre U. and Bergholdt R. (1995) Cytokines and the endocrine system. 1. The immunoendocrine network. Eur. J. Endocrinol. 133: 660-671
4. Auernhammer C. J. and Strasburger C. J. (1995) Effects of growth hormone and insulin-like growth factor on the immune system. Eur. J. Endocrinol. 133: 635-645
5. Palmetshofer A., Zechner D., Luger T. A. and Barta A. (1995) Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol. Cell Endocrinol. 113: 225-234
6. Schanke J. T., Conwell C. M., Durning M., Fisher J. M. and Golos T. G. (1997) Pit-1 growth hormone factor 1 splice variant expression in the rhesus monkey pituitary gland and the rhesus and human placenta. J. Clin. Endocrinol. Metab. 82: 800-807
7. Pfaeffle R., Kim C., Otten B., Wit J. M., Eiholzer U., Heimann G. and Parks J. (1996) Pit-1: clinical aspects. Horm. Res. 45: 25-28
8. Cohen L. E., Wondisford F. E. and Radovick S. (1996) Role of Pit-1 in the gene expression of growth hormone, prolactin and thyrotropin. Endocrinol. Metabol. Clin. North Am. 25: 523-540
9. Argetsinger L. S. and Carter-Su C. (1996) Mechanism of signaling by growth hormone receptor. Physiol. Rev. 76: 1089-1107
10. Goffin V. and Kelly P. A. (1996) Prolactin and growth hormone receptors. Clin. Endocrinol. (Oxf.) 45: 247-255
11. Han Y., Leaman D. W., Watling D., Rogers N. C., Groner B., Kerr I. M. et al. (1996) Participation of JAK and STAT proteins in growth hormone-induced signaling. J. Biol. Chem. 271: 5947-5952
12. Harding P. A., Wang X., Okada S., Chen W. Y., Wan W. and Kopchick J. J. (1996) Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J. Biol. Chem. 271: 6708-6712
13. Sobrier M. L., Dastot F., Duquesnoy P., Kandemir N., Yordam N., Goossens M. et al. (1997) Nine novel growth hormone receptor gene mutations in patients with Laron syndrome. J. Clin. Endocrinol. Metab. 82: 435-437
14. Baumann G. (1996) Growth hormone-binding proteins an overview. Acta Paediatr. 85: 95-97
15. Postel-Vinay M. C. (1996) Growth hormone-binding protein: biological significance. Acta Paediatr. 85: 98-101
16. Salmon W. D. Jr. and Burkhalter V. J. (1997) Stimulation of sulfate and thymidine incorporation into hypophysectomized rat cartilage by growth hormone and insulin-like growth factor-I in vitro: the somatomedin hypothesis revisited. J. Lab. Clin. Med. 129: 430-438
17. Stewart C. E. H. and Rotwein P. (1996) Growth, differentiation and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76: 1005-1026
18. Le Roith D., King G. and Flier J. S. (1997) Insulin-like growth factors. N. Engl. J. Med. 336: 633-639
19. Louvi A., Accili D. and Efstratiadis A. (1997) Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol. 189: 33-48
20. Cheatham B. and Kahn C. R. (1995) Insulin action and the insulin signaling network. Endocr. Rev. 16: 117-142
21. Morrione A., Valentinis B., Resnicoff M., Xu S. Q. and Baserga R. (1997) The role of mGrb10Alpha in insulin-like growth factor 1-mediated growth. J. Biol. Chem. 272: 26382-26387
22. Baserga R., Hongo A., Rubini M., Prisco M. and Valentinis B. (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta Rev. Cancer 1332: F105-F126
23. Leventhal P. S. and Feldman E. L. (1997) Insulin-like growth factors as regulators of cell motility signaling mechanisms. Trends Endocrinol. Metab. 8: 1-6
24. Werner H. and LeRoith D. (1996) The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res. 68: 183-223
25. Singleton J. R., Dixit V. M. and Feldman E. L. (1996) Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271: 31791-31794
26. Valerio G., Bond H. M., Badolato R., Petrella A., Di Maio S., Salerno M. et al. (1997) Expression of growth hormone receptor by peripheral blood lymphocytes in children: evaluation in clinical conditions of impaired growth. Clin. Endocrinol. (Oxf.) 47: 329-335
27. Hattori Y., Vera J. C., Rivas C. I., Bersch N., Bailey R. C., Geffner M. E., et al. (1996) Decreased insulin-like growth factor I receptor expression and function in immortalized African Pygmy T cells. J. Clin. Endocrinol. Metab. 81: 2257-2263
28. Federici M., Lauro D., D'Adamo M., Giovannone B., Porzio O., Mellozzi M. et al. (1998) Expression of insulin IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Diabetes 47: 87-92
29. Tally M. and Hall K. (1990) Insulin-like growth factor II effects mediated through insulin-like growth factor II receptors. Acta Paediatr. Scand. 79 Suppl. 367: 67-73
30. Zhang Q. M., Hall K. and Tally M. (1996) Partial purification of an IGF-II receptor binding protein from the erythroleukemia cell line K562. Mol. Cell Biol. 154: 47-54
31. Minniti C. P., Kohn E. C., Grubb J. H., Sly W. S., Oh Y., Muller H. L. et al. (1992) The insulin-like growth factor II (IGF-II) mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells. J. Biol. Chem. 267: 9000-9004
32. Zhang Q. M., Tally M., Larsson O., Kennedy R. T., Huang L., Hall K. and Berggren P. O. (1997) Insulin-like growth factor II signaling through the insulin-like growth factor II mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells. Proc. Natl. Acad. Sci. USA 94: 6232-6237
33. Yamada T., De Souza A. T., Finkelstein S. and Jirtle R. L. (1997) Loss of the gene encoding mannose 6-phosphate insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA 94: 10351-10355
34. Hankins G. R., De Souza A. T., Bentley R. C., Patel M. R., Marks J. R., Iglehart J. D. et al. (1996) M6P IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12: 2003-2009
35. Volpert O., Jackson D., Bouck N. and Linzer D. I. H. (1996) The insulin-like growth factor II mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137: 3871-3876
36. Kang J. X., Li Y. Y. and Leaf A. (1997) Mannose-6-phosphate insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc. Natl. Acad. Sci. USA 94: 13671-13676
37. Lau M. M. H., Stewart C. E. H., Liu Z., Bhatt H., Rotwein P. and Stewart C. L. (1994) Loss of the imprinted IGF2 cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8: 2953-2963
38. Ludwig T., Eggenschwiler J., Fisher P., D'Ercole A. J., Davenport M. L. and Efstratiadis A. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177: 517-535
39. Wu H. K., Weksberg R., Minden M. D. and Squire J. A. (1997) Loss of imprinting of human insulin-like growth factor II gene. IGF2, in acute myeloid leukemia. Biochem. Biophys. Res. Commun. 231: 466-472
40. Nishiura T., Karasuno T., Yoshida H., Nakao H., Ogawa M., Horikawa Y. et al. (1996) Functional role of cation-independent mannose 6-phosphate insulin-lik growth factor II receptor in cell adhesion and proliferation of a human myeloma cell line OPM-2. Blood 88: 3546-3554
41. Dennis P. A. and Rifkin D. B. (1991) Cellular activation of latent transforming growth factor Beta requires binding to the cation-independent mannose 6-phosphate insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88: 580-584
42. De Bleser P. J., Jannes P., Van Buul-Offers S. C., Hoogerbrugge C. M., Van Schravendijk C. F. H., Niki T. et al. (1995) Insulinlike growth factor-II mannose 6-phosphate receptor is expressed on CCl 4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 21: 1429-1437
43. Rajaram S., Baylink D. J. and Mohan S. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18: 801-831
44. Clemmons D. R. (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factors Rev. 8: 45-62
45. Zapf J. (1995) Physiological role of the insulin-like growth factor binding proteins. Eur. J. Endocrinol. 132: 645-654
46. Oh Y., Muller H. L., Pham H. and Rosenfeld R. G. (1993) Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 268: 26045-26048
47. Leal S. M., Liu Q. J., Huang S. S. and Huang J. S. (1997) The type V transforming growth factor Beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 272: 20572-20576
48. Conover C. A. (1992) Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191-3199
49. Mohseni-Zadeh S. and Binoux M. (1997) Insulin-like growth factor (IGF) binding protein-3 interacts with the type IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 138: 5645-5648
50. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B. R. et al. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649
51. Valentinis B., Bhala A., DeAngelis T., Baserga R. and Cohen P. (1995) The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9: 361-367
52. Rajah R., Valentinis B. and Cohen P. (1997) Insulin like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β-1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272: 12181-12188
53. Youngman O., Muller H. L., Ng L. and Rosenfeld R. G. (1995) Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 270: 13589-13592
54. Wilson E. M., Oh Y. and Rosenfeld R. G. (1997) Generation and characterization of an IGFBP-7 antibody: identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J. Clin. Endocrinol. Metab. 82: 1301-1303
55. Kim H. S., Nagalla S. R., Oh Y., Wilson E., Roberts C. T. Jr. and Rosenfeld R. G. (1997) Identification of a family of low-affinity insulin-like growth factor binding proteins (IGF-BPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc. Natl. Acad. Sci. USA 94: 12981-12986
56. Yamanaka Y., Wilson E. M., Rosenfeld R. G. and Oh Y. (1997) Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J. Biol. Chem. 272: 30729-30734
57. Sara V. R., Carlsson-Skwirut C., Andersson C., Hall E., Sjogren B., Holmgren A. et al. (1986) Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 83: 4904-4907
58. Yamamoto H. and Murphy L. J. (1994) Generation of Des-(1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 135: 2432-2439
59. Van den Brande J. L. (1992) Structure of the human insulin-like growth factors: relationship to function. In: The Insulin-like Growth Factors. Structure and Biological Functions, pp. 12-44, Schofield P. N. (ed.), Oxford University Press, Oxford
60. Jansson M., Uhlen M. and Nilsson B. (1997) Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein I and IGF-I receptor. Biochemistry 36: 4108-4117
61. Guan J., Williams C. E., Skinner S. J. M., Mallard E. C. and Gluckman P. D. (1996) The effects of insulin-like growth factor (IGF)-1, IGF-2 and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins. Endocrinology 137: 893-898
62. Maake C., Yamamoto H. and Murphy L. J. (1997) The growth hormone dependent serine protease inhibitor, Spi 2.1 inhibits the des (1-3) insulin-like growth factor-1 generating protease. Endocrinology 138: 5630-5636
63. Manes S., Mira E., Barbacid M. D., Cipres A., Fernandez-Resa P., Buesa J. M. et al. (1997) Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J. Biol. Chem. 272: 25706-25712
64. Fowlkes J. L. (1997) Insulin-like growth factor-binding protein proteolysis an emerging paradigm in insulinlike growth factor physiology. Trends Endocrinol. Metab. 8: 299-306
65. Rajah R., Bhala A., Nunn S. E., Peehl D. M. and Cohen P. (1996) 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137: 2676-2682
66. Blat C., Villaudy J. and Binoux M. (1994) In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 93: 2286-2290
67. Timmins A. C., Cotterill A. M., Hughes S. C. C., Holly J. M. P., Ross R. J. M., Blum W. et al. (1996) Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins and induction of an insulin-like growth factor binding protein 3 protease. Crit. Care Med. 24: 1460-1466
68. Koedam J. A., Hoogerbrugge C. M. and Van Buul-Offers S. C. (1998) IGFBP-3 protease activity in Snell normal and Pit-1 deficient dwarf mice. J. Endocrinol. 156: 295-303
69. Collett-Solberg P. F. and Cohen P. (1996) The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol. Metabol. Clin. North Am. 25: 591-614
70. Dardenne M. and Savino W. (1994) Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 15: 518-523
71. Janeway C. A. Jr. and Travers P. (1996) Immunobiology. The Immune System in Health and Disease. Curr. Biol. (Lond.)
72. Arrenbrecht S. (1974) Specific binding of growth hormone to thymocytes. Nature 252: 255-257
73. Lin B., Kinoshita Y., Hato F. and Tsuji Y. (1997) Enhancement of DNA synthetic activity of thymic lymphocytes by the culture supernatant of thymus epithelial cells stimulated by growth hormone. Cell. Mol. Biol. 43: 351-359
74. Verland S. and Gammeltoft S. (1989) Functional receptors for insulin-like growth factors I and II in rat thymocytes and mouse thymoma cells. Mol. Cell. Endocrinol. 67: 207-216
75. Kooijman R., Scholtens L. E., Rijkers G. T. and Zegers B. J. M. (1995) Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes. J. Endocrinol. 147: 203-209
76. Maggiano N., Piantelli M., Ricci R., Larocca L. M., Capelli A. and Ranelletti F. O. (1994) Detection of growth hormone-producing cells in human thymus by immunohistochemistry and non-radioactive in situ hybridization. J. Histochem. Cytochem. 42: 1349-1354
77. Geenen V., Achour I., Robert F., Vandersmissen E., Sodoyez J. C., Defresne M. P. et al. (1993) Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin super-family. Thymus 21: 115-127
78. Van Der Ven L. T. M., Roholl P. J. M., Reijnen-Gresnigt M. G., Bloemen R. J. and Van Buul-Offers S. C. (1997) Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II. Histochem. Cell. Biol. 107: 193-203
79. Han V. K. M., Matsell D. G., Delhanty P. J. D., Hill D. J., Shimasaki S. and Nygard K. (1996) IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Horm. Res. 45: 160-166
80. Braulke T., Claussen M., Saftig P., Wendland M., Neifer K., Schmidt B. et al. (1995) Proteolysis of IGFBPs by cathepsin D in vitro and in cathepsin D-deficient mice. Prog. Growth Factor Res. 6: 265-271
81. Nagy E. and Berczi I. (1978) Immunodeficiency in hypophysectomized rats. Acta Endocrinol. 89: 530-537
82. Guler H., Zapf J., Scheiwiller E. and Froesch E. R. (1988) Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. USA 85: 4889-4893
83. Fukushima R., Hato F., Kinoshita Y., Tsuji Y. and Kitano A. (1997) Effect of exogenous growth hormone on in vitro proliferation of thymic lymphocytes from the hypophysectomized rats. Cell. Mol. Biol. 43: 567-579
84. Sornson M. W., Wu W., Dasen J. S., Flynn S. E., Norman D. J., O'Connell S. M. et al. (1996) Pituitary lineage determination by the prophet of pit-1 homeodomain factor defective in ames dwarfism. Nature 384: 327-333
85. Van Buul-Offers S. C. (1983) Hormonal and other inherited growth disturbances in mice with special reference to the Snell dwarf mouse. A review. Acta. Endocrinol. 103 (Suppl. 258): 1-47
86. Baroni C. (1967) Thymus, peripheral lymphoid tissues and immunological responsiveness of the pituitary dwarf mouse. Experientia 23/4: 282-283
87. Duquesnoy R. J. (1972) Immunodeficiency of the thymus-dependent system of the ames dwarf mouse. J. Immunol. 108: 1578-1590
88. Van Buul-Offers S. C. and Van den Brande J. L. (1982) Cellular growth in several organs of normal and dwarfed Snell mice. Acta Endocrinol. 99: 141-149
89. Pandian M. R. and Talwar G. P. (1971) Effect of growth hormone on the metabolism of thymus and on the immune response against sheep erythrocytes. J. Exp. Med. 134: 1095-1113
90. Van Buul-Offers S. C., Ueda I. and Van den Brande J. L. (1986) Biosynthetic somatomedin-C (SM-C IGF-1) increases the lenght and weight of Snell dwarf mice. Pediatr. Res. 20: 825-827
91. Pierpaoli W., Baroni C., Fabris N. and Sorkin E. (1969) Hormones and Immunological capacity II reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin. Immunology 16: 217-230
92. Van Buul-Offers S. C. and Van den Brande J. L. (1982) Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity. Acta Endocrinol. 99: 150-160
93. Takada Y., Bando H., Miyamoto Y., Kosaka M. and Sano T. (1991) Effect of growth hormone on immune function in normal and hypophysectomized rats. Folia Endocrinol. 67: 1162-1177
94. Kelley K. W. (1995) Immunologic roles of two metabolic hormones, growth hormone and insulin-like growth factor-I, in aged animals. Nutr. Rev. 53: S95-S104
95. Bar-Dayan Y. and Small M. (1994) Effect of bovine growth hormone administration on the pattern of thymic involution in mice. Thymus 23: 95-101
96. Beschorner W. E., Divic J., Pulido H., Yao X., Kenworthy P. and Bruce G. (1991) Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor I. Transplantation 52: 879-884
97. Weigent D. A. and Blalock J. E. (1994) Effect of the administration of growth-hormone-producing lymphocytes on weight gain and immune function in dwarf mice. Neuroimmunomodulation 1: 50-58
98. Pierpaoli W. and Sorkin E. (1968) Hormones and immunologic capacity. 1. Effect of heterologous anti-growth hormone (ASTH) antiserum on thymus and peripheral lympatic tissue in mice. Induction of a wasting syndrome. J. Immunol. 101: 1036-1043
99. Shea B. T., Hammer R. E. and Brinster R. L. (1987) Growth allometry of the organs in giant transgenic mice. Endocrinology 121: 1924-1930
100. Cecim M., Bartke A., Yun J. G. and Wagner T. E. (1993) Growth allometry of transgenic mice expressing the mouse metallothionein-1 bovine growth hormone gene. Transgene 1: 125-132
101. Yamada M., Hato F., Kinoshita Y., Tominaga K. and Tsuji Y. (1994) The indirect participation of growth hormone in the thymocyte proliferation system. Cell. Mol. Biol. 40: 111-121
102. Siddiqui R. A., McCutcheon S. N., Blair H. T., Mackenzie D. D. S., Morel P. C. H., Breier B. H. et al. (1992) Growth allometry of organs, muscles and bones in mice from lines divergently selected on the basis of plasma insulin-like growth factor-I. Growth Dev. Ageing 56: 53-60
103. Timsit J., Savino W., Safieh B., Chanson P., Gagnerault M. C., Bach J. F. et al. (1992) Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metab. 75: 183-188
104. Tomas F. M., Lemmey A. B., Read L. C. and Ballard F. J. (1996) Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection. J. Endocrinol. 150: 77-84
105. Lemmey A. B., Martin A. A., Read L. C., Tomas F. M., Owens P. C. and Ballard F. J. (1991) IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. Am. Physiol. Soc. 260: E213-E219
106. Clark R., Strasser J., McCabe S., Robbins K. and Jardieu P. (1993) Insulin-like growth factor-I stimulation of lymphopoiesis. J. Clin. Invest. 92: 540-548
107. Binz K., Joller P., Froesch P., Binz H., Zapf J. and Froesch E. R. (1990) Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 87: 3690-3694
108. van Buul-Offers S. C., Hoogerbrugge C. M., Branger J., Feijlbrief M. and Van den Brande J. L. (1988) Growth-stimulating effects of somatomedin- insulin-like peptides in Snell dwarf mice. Horm. Res. 29: 229-236
109. van Buul-Offers S. C., Reijnen-Gresnigt M. G., Hoogerbrugge C. M., Bloemen R. J., Kuper C. F. and Van den Brande J. L. (1994) Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology 135: 977-985
110. van Buul-Offers S. C., De Haan K., Reijnen-Gresnigt M. G., Meinsma D., Jansen M., Oei S. L. et al. (1995) Overexpression of human IGF-II in transgenic mice causes increased growth of the thymus. J. Endocrinol. 144: 491-502
111. Kooijman R., Van Buul-Offers S. C., Scholtens L. E., Reijnen-Gresnigt R. G. and Zegers B. J. M. (1997) T and B cell development in pituitary deficient insulin-like growth factor-II transgenic dwarf mice. J. Endocrinol. 155: 165-170
112. Kooijman R., Van Buul-Offers S. C., Scholtens L. E., Schuurman H-J., Van den Brande J. L. and Zegers B. J. M. (1995) T cell development in insulin-like growth factor-II transgenic mice. J. Immunol. 15: 5736-5745
113. Koster J. G., Reijnen-Gresnigt M. G., Bloemen R. J., Stegeman B. I. and Van Buul-Offers S. C. (1996) Differences in growth regulation by IGF-II and IGFBP3 in lymphoid tissues of IGF-II transgenic mice. 10th International Congress of Endocrinology, San Francisco, CA, P2-253
114. Ward A., Bates P., Fisher R., Richardson L. and Graham C. F. (1994) Disproportionate growth in mice with Igf-2 transgenes. Proc. Natl. Acad. Sci. USA 91: 10365-10369
115. Rogler C. E., Yang D., Rossetti L., Donohoe J., Alt E., Chang C. J. et al. (1994) Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem. 269: 13779-13784
116. Wolf E., Kramer R., Blum W. F., Foell J. and Brem G. (1994) Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 135: 1877-1886
117. Badolato R., Bond H. M., Valerio G., Petrella A. A., Morrone G., Waters M. J. et al. (1994) Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J. Clin. Endocrinol. Metab. 799: 984-990
118. Gelato M. C. (1996) Aging and immune function: a possible role for growth hormone. Horm. Res. 45: 46-49
119. Kooijman R., Willems M., de Haas C. J. C., Rijkers G. T., Schuurmans A. L. G., Van Buul-Offers S. C. et al. (1992) Expression of type 1 insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131: 2244-2250
120. Federici M., Porzio O., Zucaro L., Fusco A., Borboni P., Lauro D. et al. (1997) Distribution of insulin insulin-like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol. 129: 121-126
121. Bailyes E. M., Nave B. T., Soos M. A., Orr S. R., Hayward A. C. and Siddle K. (1997) Insulin receptor IGP-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J. 327: 209-215
122. Lee P. D. K., Rosenfeld R. G., Hintz R. L. and Smith S. D. (1986) Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J. Clin. Endocrinol. Metab. 62: 28-35
123. Weigent D. A., Baxter J. B. and Blalock J. E. (1992) The production of growth hormone and insulin-like growth faclor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav. Immun. 6: 365-376
124. Varma S., Sabharwal P., Sheridan J. F. and Malarkey W. B. (1993) Growth hormone secretion by human perpheral blood monocuclear cells detected by an enzyme-linked immunoplague assay. J. Clin. Endocrinol. Metab. 76: 49-53
125. Baxter J. B., Blalock J. E. and Weigent D. A. (1991) Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 129: 1727-1734
126. Arkins S., Rebeiz N., Biragyn A., Reese D. L. and Kelley K. W. (1993) Murine macrophages express abundant insulin-like growth factor-I Class I Ea and Eb transcripts. Endocrinology 133: 2334-2343
127. D'Ercole A. J., Stiles A. D. and Underwood L. E. (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. USA 81: 935-939
128. Hansson H. A., Nilsson A., Isgaard J., Billig H., Isaksson O., Skottner A. et al. (1988) Immunohistochemical localization of insulin-like growth factor I in the adult rat. Histochemistry 89: 403-410
129. Murphy E. J., Bell G. I. and Friesen H. G. (1987) Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 120: 1279-1282
130. Nyman T. and Pekonen F. (1993) The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol. 128: 168-172
131. Merimee T. J., Grant M. B., Broder C. M. and Cavalli-Sforza L. L. (1989) Insulin-like growth factor secretion by human B-lymphocytes: a comparison of cells from normal and pygmy subjects. J. Clin. Endocrinol. Metab. 69: 978-984
132. Weigent D. A., Blalock J. E. and LeBoeuf R. D. (1991) An antisense oligodooxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. Endocrinology 128: 2053-2057
133. Villanua M. A., Szary A., Bartke A. and Esquifino A. I. (1992) Changes in lymphoid organs of Ames dwarf mice after treatment with growth hormone, prolactin or ectopic pituitary transplants. J. Endocrinol. Invest. 15: 587-595
134. Dumont F., Robert F. and Bischoff P. (1979) T and B lymphocytes in pituitary dwarf Snell-Bagg mice. Immunology 38: 23-31
135. Fabris N., Pierpaoli W. and Sorkin E. (1971) Hormones and the immunological capacity. IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse. Clin. Exp. Immunol. 9: 227-240
136. Thissen J. P., Underwood L. E., Maiter D., Maes M., Clemmons D. R. and Ketelslegers J. M. (1991) Failure of insulin-like growth factor-I (IGF-I) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations. Endocrinology 128: 885-890
137. Conlon M. A., Francis G. L., Tomas F. M., Wallace J. C., Howarth G. S. and Ballard F. J. (1995) Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. J. Endocrinol. 144: 91-98
138. Wanke R., Hermanns W., Folger S., Wolf E. and Brem G. (1991) Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: an overview. Pediatr. Nephrol. 5: 513-521
139. Wanke R., Wolf E., Hermanns W., Folger S., Buchmueller T. and Brem G. (1992) The GH-transgenic mouse as an experimental model for growth research: clinical and pathological studies. Horm. Res. 37: 74-87
140. Gruaz N. M., D'Alleves V., Charnay Y., Skottner A., Ekvaern S., Fryklund L. et al. (1997) Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth, and sexual function evidence that such treatment does not affect sexual maturation or fertility. Endocrine 6: 11-19
141. Mathews L. S., Hammer R. E., Behringer R. R., D'Ercole A. J., Bell G. I., Brinster R. L. et al. (1988) Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123: 2827-2833
142. Quaife C. J., Mathews L. S., Pinkeert C. A., Hammer R. E., Brinster R. L. and Palmiter R. D. (1989) Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 124: 40-48
143. Backeljauw P. F., Underwood L. E., Miras M., Arriazu M. C., Heinrich J., Ghizzoni L. et al. (1996) Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome a clinical research center study. J. Clin. Endocrinol. Metab. 81: 3312-3317
144. Jardieu P., Clark R., Mortensen D. and Dorshkind K. (1994) In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J. Immunol. 152: 4320-4327
145. LeRoith D., Yanowski J., Kaldjian E. P., Jaffe E. S., LeRoith T., Purdue K. et al. (1996) The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137: 1071-1079
146. Montecino-Rodriguez E., Clark R., Johnson A., Collins L. and Dorshkind K. (1996) Defective B cell development in Snell dwarf (dw dw) mice can be corrected by thyroxine treatment. J. Immunol. 157: 3334-3340
147. Gala R. R. (1995) Influence of thyroxine and thyroxine with growth hormone and prolactin on splenocyte subsets and on the expression of interleukin-2 and prolactin receptors on splenocyte subsets of Snell dwarf mice. Proc. Soc. Exp. Biol. Med. 210: 117-125
148. Murphy L. J., Molnar P., Lu X. and Huang H. (1995) Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J. Mol. Endocrinol. 15: 293-303
149. Murphy L. J., Rajkumar K. and Molnar P. (1995) Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog. Growth Factor Res. 6: 425-432
150. Pintar J. F., Cerro J. A. and Wood T. L. (1996) Genetic approaches to the function of insulin like growth factor-binding proteins during rodent development. Horm. Res. 45: 172-177
151. Dai J. and Baxter R. C. (1994) Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex. Endocrinology 135: 2335-2341
152. Duquesnoy R. J., Kalpaktsoglou P. K. and Good R. A. (1970) Immunological studies of the Snell-Bagg pituitary dwarf mouse. Proc. Soc. Exp. Biol. Med. 133: 201-206
153. Robbins K., McCabe S., Scheiner T., Strasser J., Clark R. and Jardieu P. (1994) Immunological effects of insulin-like growth factor-1-Enhancement of immunoglobulin synthesis. Clin. Exp. Immunol. 95: 337-342
154. Nagy E., Berczi I. and Friesen H. G. (1983) Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 102: 351-357
155. Wit J. M., Kooijman R., Rijkers G. T. and Zegers B. J. M. (1993) Immunological findings in growth hormone-treated patients. Horm. Res. 39: 107-110
156. Geffner M. (1997) Effects of growth hormone and insulin-like growth factor I on T-and B-lymphocytes and immune function. Acta Paediatr. 86: 76-79
157. Kirstein M., Aston C., Hintz R. and Vlassara H. (1992) Receptor-specific induction of insulin-like growth factor-I in human monocytes by advanced glycosylation and product-modified proteins. J. Clin. Invest. 90: 439-446
158. Arkins S., Rebeiz N., Brunke-Reese D. L., Biragyn A. and Kelley K. W. (1995) Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol. Endocrinol. 9: 350-360
159. Kooijman R., Malur A., Van Buul-Offers S. C. and Hooghe-Peters E. L. (1997) Growth hormone expression in murine bone marrow cells is independent of the pituitary transcription factor Pit-1. Endocrinology 138: 3949-3955
160. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V. et al. (1997) Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I a model for stunted growth in children with chronic inflammation. J. Clin. Invest. 99: 643-650